Catalyst Wire Dossier Catalyst Wire Dossier

ART-123

recombinant human soluble thrombomodulin
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ART-123, covering 2011-05-18 to 2024-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients [Phase 1]

See pricing